Region Care Infusion
Infusion Therapy Services at Home
|
RegionCare Infusion, a division of the North Shore–LIJ Home Care Network, makes it possible for people of any age who need intravenous or injectable medications to receive professional care and treatment in the comfort of their own home. Services are available to patients on Long Island and in the New York Metropolitan area. RegionCare's infusion services at home enable many patients to resume their normal lifestyle.
RegionCare's experienced infusion nurses, pharmacists, and laboratory services deliver advanced clinical and technical care, working closely with the prescribing physician and the patient to design a comprehensive plan of care that reflects each patient's special clinical needs.
The specialty pharmaceutical services provided by RegionCare include:
- Nutrition therapy
- Antibiotics
- Pain management
- Hydration
- Chemotherapy
Call The Home Care Network toll-free at (866) 651-4200 to discuss your personal home care needs. |
Last Update
January 22, 2010How did I get to this page?
Related Information
- News Room
-
Clinical Trials
- Chronic Lymphocytic Leukemia - Clinical Trial (08-059)
- Chronic Lymphocytic Leukemia - Ginseng Extract Study (08-264)
- Acute Lymphoblastic Leukemia - Chemotherapy and Transplantation Trial (03-151T)
- Multiple Myeloma - Maintenance Therapy vs. Placebo Study (06-031T)
- Mantle Cell Lymphoma - Randomized Clinical Trial (07-120)
- Osteonecrosis of the Jaw - Case Control Study (07.08.127)
- Chemotherapy - Peripheral Neuropathy Study (07.06.122)
- System Lupus Erythematosus - Study of 3.3-Diidolymethane (06.02.107T)
- Endometrial Cancer - Combination Therapy Study (04.06.122)
- Peritoneal Cancer - Treatment Comparison Study (07.06.073)
- Ovarian, Fallopian, Peritoneal Cancer - Abaxane Study (07.06.121)
- Cervical Cancer - Treatment Comparison Study (07-044)
- Peritoneal Cancer - Treatment Comparison Study (08-150)
- ADHD Medication Adherence: Parent-Provider Study (06.08.072T)
- Chronic Lymphocytic Leukemia - Hydroxychloroquine Study (08-088)
- Burkitt Lymphoma/Leukemia - Clinical Trial (02-101T)
- Acute Leukemia - Multidrug Resistance Studies (02-214)
- Acute Promyelocytic Leukemia - Clinical Trial (08-061)
- Acute Promyelocytic Leukemia - Clinical Trial (08-135)
- Acute Myeloid Leukemia - Clinical Trial (08-255)
- Brain AVM - Clinical Trial (06.02.063)
- Bipolar Disorder - Clinical Trial (08-001)
- Colon and Rectal Cancer - Clinical Trial (06.06.001T)
- Gastric and Gastroesphageal Cancer - Clinical Trial (07.06.041)
- Prostate Cancer - Clinical Trial (08-004)
- Colorectal Cancer - Clinical Trial (07.06.123)
- Bipolar Susceptibility Study (08-132)
- Schizophrenia - Clinical Trial (05.04.086)
- Renal Carcinoma - Clinical Trial (07.06.139)
- Non-Small Cell Lung Cancer - Clinical Trial (07.06.124)
- Renal Cell Carcinoma - The BeST Trial (08-180)
- Smoking Cessation - Lozenge vs. Patch (06-030)
- Respiratory Papillomatosis - Celebrex Study (03.02.131)
- Chemotherapy - Nausea Treatment Study (03-108T)
- Prevention of Delayed Nausea- Clinical Trial (07.06.120)
- Lapatinab in Endocrine-Resistant Metastic Breast Cancer (06.06.105)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-190)
- CF - Expanded Access Study (07-02-201)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-81)
- Systemic Lupus Erythematosus - Clinical Trial (08-02-145)
- HIV - Clinical Trial (08-02-160)
- Asthma - Clinical Trial (08-02-188)
- Systemic Lupus Erythematosus - Clinical Trial (08-02-207)
- B-Cell Chronic Lymphocytic Leukemia Study (08-06-217)
- Diabetes Study (08-046)
- Cystitis-Painful Bladder Study - (08-269)
- Pelvic Pain Study - (08-274)
- Lung Cancer - Clinical Trial (08-282)
- Schizophrenia - Clinical Trial (08-296)
- Rectal Cancer - Clinical Trial (09-003)
- Lung Cancer - Clinical Trial (09-004)
- Gynecologic Cancer - Clinical Trial (09-006)
- COPD - Clinical Trial (09-02-110)
- Chronic Abacterial Prostatitis - Clinical Trial (09-02-69)
- Solid Tumors - Combination Treatment Study (09-06-152)
- Systemic Lupus Erythematosus Study (09-122)
- Benvacizamab with IV versus IP Chemotherapy Study (09-245)
- Endometrial Carcinoma Study (09-246)
- Endometrial Carcinoma Study (09-247)
- Cervical Cancer Study (09-275B)
- Acute Promyelocytic Leukemia Study (09-184)
- Prostate Cancer Study ()
- Metastatic Cancer Study (09-093)
- Women with Epilepsy - Pregnancy Outcomes and Deliveries - WEPOD
General Navigation
Persistent Navigation
-
Services
-
All Services
- Bariatric Surgery
- Behavioral Health
- CAM - Complementary and Alternative Medicine
- Cushing Neuroscience Institutes
- Gastroenterology
- Heart Health
- Home Healthcare
- Imaging/Radiology
- Learn About the Cancer Institute
- Nephrology
- Occupational and Environmental Medicine
- Ophthalmology
- Orthopaedics
- Otolaryngology
- Pathology and Laboratory Medicine
- Pediatrics
- Radiation Medicine
- Rehabilitation
- Rheumatology
- Senior Services
- Surgery
- Thoracic Surgery
- Urogynecology
- Urology
- Women's Health
- Wound Care
- Cancer
- Heart Health
- Home Healthcare
- Imaging/Radiology
- Neurosciences
- Orthopaedics
- Pediatrics
- Surgery
- Urology
- Women's Health
-
All Services